IFNG Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">IFNG Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>IFNG</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>IFNG</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=IFNG" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's disease</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">285 edges</a></td>
</tr>
</table>
Pathway Diagram
Mermaid diagram (expand to render)
Ifng Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
IFNG is involved in neurodegenerative diseases. This page provides comprehensive information about its function, disease associations, expression patterns, molecular mechanisms, and therapeutic implications. [@ifnga]
[@ifngb]
'''IFNG''' (Interferon Gamma) is a critical cytokine that plays central roles in both antiviral immunity and neuroinflammation. It is produced primarily by natural killer cells and T lymphocytes and has complex effects on neurodegenerative processes. [@ifngc]
Function
IFN-γ is a homodimeric type II interferon that signals through the IFNGR1/IFNGR2 receptor complex. It is a potent immunomodulator with both pro-inflammatory and immunoregulatory functions. [@cytokines]
Key functions:
- Macrophage activation: Classic activation (M1) of [microglia](/cell-types/microglia-neuroinflammation)
- Antiviral immunity: Induces antiviral state in cells
- MHC expression: Upregulates antigen presentation
- Th1 differentiation: Promotes pro-inflammatory T cell responses
- [Blood-brain barrier](/entities/blood-brain-barrier): Modulates BBB permeability
Disease Associations
Alzheimer's Disease
- Elevated IFNG in AD brain and CSF
- May promote chronic neuroinflammation
- Interactions with amyloid pathology
- Therapeutic targeting complex (dual roles)
Parkinson's Disease
- Increased IFNG in substantia nigra
- Associated with microglial activation
- May contribute to dopaminergic neuron loss
- Complex role in neuroinflammation
Multiple Sclerosis
- Central role in EAE (MS model)
- IFNG therapy caused disease exacerbation
- IFNG neutralization studies
- Critical for autoimmune demyelination
Amyotrophic Lateral Sclerosis
- Elevated in ALS CSF and tissue
- May accelerate motor neuron degeneration
- Modulates neuroinflammation
- Therapeutic target
Expression
IFNG expression in the brain:
- [Microglia](/entities/microglia): Inducible expression
- Infiltrating T cells: Primary source
- [Astrocytes](/entities/astrocytes): Low basal expression
- [Neurons](/entities/neurons): Rare
Induced by:
- Viral infections
- Inflammatory stimuli
- TLR activation
Molecular Mechanisms
IFNG signaling:
Receptor binding: IFNGR1/IFNGR2
JAK/STAT pathway: STAT1 activation
ISG expression: Interferon-stimulated genes
Antiviral response: PKR, OAS, MX proteins
MHC upregulation: Antigen presentationTherapeutic Implications
Therapeutic approaches:
- IFNG neutralization: Antibodies in MS trials
- JAK inhibitors: Downstream blockade
- Immunomodulation: Balancing pro/anti-inflammatory
- Caution needed: Dual roles complicate therapy
See Also
- [IFNG Protein](/proteins/ifng-protein)
- [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
External Links
- [NCBI Gene: IFNG](https://www.ncbi.nlm.nih.gov/gene/3458)
- [UniProt: P01579](https://www.uniprot.org/uniprot/P01579)
- [GeneCards: IFNG](https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNG)
Signaling Mechanisms
JAK-STAT Pathway
IFN-γ signaling through JAK-STAT pathway is central to its immune modulatory functions. Binding of IFN-γ to its receptor activates JAK1 and JAK2 tyrosine kinases, leading to STAT1 phosphorylation and dimerization. The STAT1 homodimer translocates to the nucleus and binds to GAS (IFN-γ-activated sequence) elements, driving transcription of immune response genes.
IRF Activation
IFN-γ also activates interferon regulatory factors (IRFs), particularly IRF1 and IRF8, which orchestrate antigen presentation and immune cell differentiation. IRF1 serves as a transcriptional activator of MHC class I and II molecules, essential for adaptive immune responses.
Cross-talk Pathways
- [mTOR](/entities/mtor) signaling: Metabolic regulation in activated immune cells
- Notch pathway: Dendritic cell differentiation
- Wnt signaling: Modulation of inflammatory responses
Neurobiological Functions
Microglial Activation
IFN-γ is a potent microglial activator, inducing MHC class II expression and antigen presentation. Activated microglia release pro-inflammatory cytokines, [reactive oxygen species](/entities/reactive-oxygen-species), and nitric oxide, which can be neuroprotective or neurotoxic depending on context.
Neuronal Vulnerability
Chronic IFN-γ exposure contributes to neuronal dysfunction through:
- Synaptic pruning: Enhanced elimination of synapses
- Excitotoxicity: Modulation of glutamate receptor function
- Oxidative stress: Induction of NADPH oxidase
- [Apoptosis](/entities/apoptosis): Caspase-dependent cell death pathways
Therapeutic Implications
Autoimmune and Inflammatory Diseases
- Multiple sclerosis: IFN-γ may exacerbate disease
- Rheumatoid arthritis: Targeting IFN-γ pathways
- Inflammatory bowel disease: Role in gut inflammation
Neurodegenerative Diseases
- Alzheimer's disease: Mixed evidence for therapeutic targeting
- Parkinson's disease: Potential neuroprotective strategies
- ALS: Modulating microglial activation
Cancer Immunotherapy
- Immunomodulatory effects: Enhancing anti-tumor immunity
- Blood-brain barrier: Considerations for CNS tumors
Background
The study of Ifng Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, - IFNG structure and function (n.d.)](https://pubmed.ncbi.nlm.nih.gov/2987224/)
[Unknown, - IFNG in CNS (n.d.)](https://pubmed.ncbi.nlm.nih.gov/1378680/)
[Unknown, - IFNG and neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/8338156/)
[Unknown, - IFNG in MS (n.d.)](https://pubmed.ncbi.nlm.nih.gov/11137986/)
[Unknown, - Cytokines in ALS (n.d.)](https://pubmed.ncbi.nlm.nih.gov/18599346/)Pathway Diagram
The following diagram shows the key molecular relationships involving IFNG Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)